Developmental pharmacokinetics and pharmacodynamics of parenteral opioids and nonsteroidal anti-nflammatory drugs in neonates and infants

[1]  L. Vutskits.  More Than Anyone Else: Preemies Need Good Analgesia. , 2016, Anesthesiology.

[2]  J. Galinkin,et al.  Personalizing Pediatric Pain Medicine: Using Population-Specific Pharmacogenetics, Genomics, and Other –Omics Approaches to Predict Response , 2015, Anesthesia and analgesia.

[3]  T. Klein,et al.  Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update , 2014, Clinical pharmacology and therapy.

[4]  D. Tibboel,et al.  Evidence-Based Morphine Dosing for Postoperative Neonates and Infants , 2014, Clinical Pharmacokinetics.

[5]  D. Tibboel,et al.  Effect of intravenous paracetamol on postoperative morphine requirements in neonates and infants undergoing major noncardiac surgery: a randomized controlled trial. , 2013, JAMA.

[6]  M. Hayden,et al.  More Codeine Fatalities After Tonsillectomy in North American Children , 2012, Pediatrics.

[7]  P. Vicini,et al.  Ketorolac tromethamine: stereo‐specific pharmacokinetics and single‐dose use in postoperative infants aged 2–6 months , 2011, Paediatric anaesthesia.

[8]  K. Allegaert,et al.  The pharmacokinetics of intravenous paracetamol in neonates: size matters most , 2011, Archives of Disease in Childhood.

[9]  E. Kharasch,et al.  Pharmacology of Pediatric Anesthesia , 2011 .

[10]  Imti Choonara,et al.  Predictive Performance of a Recently Developed Population Pharmacokinetic Model for Morphine and its Metabolites in New Datasets of (Preterm) Neonates, Infants and Children , 2011, Clinical pharmacokinetics.

[11]  B. Anderson,et al.  Are there still limitations for the use of target-controlled infusion in children? , 2010, Current opinion in anaesthesiology.

[12]  B. Anderson.  Pediatric models for adult target‐controlled infusion pumps , 2010, Paediatric anaesthesia.

[13]  R. Brant,et al.  The effect of age on the dose of remifentanil for tracheal intubation in infants and children , 2010, Paediatric anaesthesia.

[14]  A. Gabrielli,et al.  Codeine, Ultrarapid-Metabolism Genotype, and Postoperative Death , 2009 .

[15]  R. Hunt,et al.  I.V. acetaminophen pharmacokinetics in neonates after multiple doses. , 2008, British journal of anaesthesia.

[16]  M. Crawford,et al.  Dose-Response of Remifentanil for Tracheal Intubation in Infants , 2005, Anesthesia and analgesia.

[17]  K. Allegaert,et al.  Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis 1 , 2005, Paediatric anaesthesia.

[18]  A. Lewis,et al.  Prospective randomized trial of ketorolac after congenital heart surgery. , 2004, Journal of cardiothoracic and vascular anesthesia.

[19]  D. Tibboel,et al.  Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children. , 2004, British journal of anaesthesia.

[20]  R. V. van Lingen,et al.  Pharmacokinetics of single dose intravenous propacetamol in neonates: effect of gestational age , 2004, Archives of disease in childhood. Fetal and neonatal edition.

[21]  R. Howard,et al.  Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability. , 2002, British journal of anaesthesia.

[22]  L. D. Bradford,et al.  CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. , 2002, Pharmacogenomics.

[23]  C. D. Kurth,et al.  A Randomized Multicenter Study of Remifentanil Compared with Halothane in Neonates and Infants Undergoing Pyloromyotomy. I. Emergence and Recovery Profiles , 2001, Anesthesia and analgesia.

[24]  A. Ross,et al.  Pharmacokinetics of Remifentanil in Anesthetized Pediatric Patients Undergoing Elective Surgery or Diagnostic Procedures , 2001, Anesthesia and analgesia.

[25]  N. Holford,et al.  Acetaminophen analgesia in children: placebo effect and pain resolution after tonsillectomy , 2001, European Journal of Clinical Pharmacology.

[26]  S. Bratton,et al.  Intravenous morphine in postoperative infants: intermittent bolus dosing versus targeted continuous infusions , 2000, Pain.

[27]  K. Hamunen,et al.  Stereoselective pharmacokinetics of ketorolac in children, adolescents and adults , 1999, Acta anaesthesiologica Scandinavica.

[28]  M. K. Aravind,et al.  Enantiomer‐selective pharmacokinetics and metabolism of ketorolac in children , 1999, Clinical pharmacology and therapeutics.

[29]  R. Eglen,et al.  Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat. , 1999, The Journal of pharmacology and experimental therapeutics.

[30]  A. Lynn,et al.  Use of remifentanil in infants , 1998, Paediatric anaesthesia.

[31]  S. Bratton,et al.  Clearance of Morphine in Postoperative Infants During Intravenous Infusion: The Influence of Age and Surgery , 1998, Anesthesia and analgesia.

[32]  M Ingelman-Sundberg,et al.  Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles. , 1996, The Journal of pharmacology and experimental therapeutics.

[33]  J. Slattery,et al.  Respiratory effects of intravenous morphine infusions in neonates, infants, and children after cardiac surgery. , 1993, Anesthesia and analgesia.

[34]  J. Slattery,et al.  The maturation of morphine clearance and metabolism. , 1992, American journal of diseases of children.

[35]  M. A. Hughes,et al.  Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. , 1992, Anesthesiology.

[36]  J. Slattery,et al.  Morphine Pharmacokinetics in Early Infancy , 1987, Anesthesiology.